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ABSTRACT
Diagnosing chronic inflammatory polyradiculopathy in patients with pre-existing diabetic sensorimotor polyneuropathy 
is a diagnostic challenge. We present a case of a 69 years old who presented with weakness of legs for two months,he 
was diagnosed as having CIDP on the background of diabetic sensorimotor polyneuropathy, further and extensive 
workup revealed the final diagnosis of nonsecretory myeloma. Diagnosing non secretory myeloma is itself a diagnostic 
challenge and usually first line investigations for the workup of myeloma are negative as was the case in our patient. 
Our patient with CIDP had raised free light chains of kappa which made the final diagnosis of kappa associated plasma 
cell dyscrasia.
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INTRODUCTION
Chronic inflammatory polyradiculopathy (CIDP) is 
clinically defined as ‘chronically progressive, stepwise 
or recurrent proximal and distal and sensory 
dysfunction of all extremities, developing over at least 
02 months, with absent or reduced tendon reflexes in 
all limbs and sometimes with cranial nerve 
involvement[1].The diagnosis of CIDP in diabetes 
patients may be significantly more difficult than in 
non-diabetics, due to mild demyelinating changes 
associated with diabetic sensorimotor polyneuropathy 
(DSP), in the setting of poor glycemic control[2].We 
present such a challenging case of 69 year old male 
from Islamabad where reaching to a final diagnosis was 
an arduous journey and in itself was a diagnostic 
challenge.
CASE REPORT:
A 69 years old male with 35 years long history of type 
2 diabetes Mellitus with complications of diabetic 
neuropathy, nephropathy CKD III, retinopathy, diabetic 
foot ulcer presented with two months history of gradual 
but rapid worsening of weakness in both legs, he was 
independent with activities of daily living prior to two 
months and was driving. The weakness was 
asymmetrical and involved left leg more than right and 
involved both proximal and distal muscles equally and 
at the same time. He denied any symptoms in upper 
limbs. There was no significant backache or urinary 
symptoms. There was longstanding numbness in both 
his feet for more than six years which was unchanged.
Examination revealed wasting of left leg, marked 
ischemic lower limbs skin changes, diabetic foot ulcer 
on right first metatarsal. There was prominent wasting 
of small muscles in hands as well. Power was 4/5 on 
left leg both proximally and distally. Power was 4+ on 
right leg both proximally and distally. He had normal 
power in upper limbs.Sensory system examination 
revealed impaired pin prick sensation in gloves and 
stocking distribution, impaired vibration and position 
sense in legs upto ankles.Investigations revealed HB of 
10.5g/dL microcytic hypochromic.His renal functions 
revealed creatinine of 2.7mg/dL and urea of 40mg/dL. 
Serum electrolytes showed low sodium of 128mmol/L, 
normal potassium and low bicarbonate of 16. His 
HbA1c was 8.7.His nerve conduction studies and 
Electromyography revealed changes suggestive of 
sensorimotor predominantly polyneuropathy with 
demyelination changes as shown in figure 1&2.Was it 
just the rapid progression of Diabetic Sensorimotor 
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exact electrophysiological criteria could not be applied 
due to the presence of diabetic sensorimotor 
polyneuropathy.Rest of the diagnostic workup showed 
negative antiganglioside antibodies including Anti GM1 
antibodies. His ANA, ENA(extractable nuclear antigen 
antibodies) were negative. His serum electrophoresis 
was normal, showing no evidence of para proteins. ESR 
was 49 and CRP was negative. MRI lumbosacral spine 
showed mild to moderate lumbar spondylosis as shown 
in figure 3.IVIG were contraindicated in our patient due 
to diabetes associated renal impairment. As oral 
corticosteroids are considered as first line treatment of 
newly diagnosed CIDP, patient was started on steroids. 
Plasma exchange was high risk in our patient due to 
presence of cardiovascular compromise and was 
offered but refused by patient. Patient was given 
corticosteroids along with Azathioprine for 06 weeks. At 
06 weeks he showed no improvement in his disability. 
However, he further developed malena, steroid induced 
gastropathy was confirmed on endoscopy which 
confirmed marked antral gastritis and gastric erosions. 
His haemoglobin dropped from 10.5 to 7.5 mg/dL. He 
also developed neutropenia probably due to 
azathioprine and developed marked oral ulcers and 
thrush rendering him nil by mouth. Steroids and 
azathioprine were therefore discontinued. As patient 
did not respond to first line treatment and we had 
difficulties with first line treatments. We underwent 
second-line investigations. Further diagnostic workup 
revealed raised serum free light chain. Free kappa were 
found to be >4380mg/L (range 3.3-19.4mg/L).Serum 
protein electrophoresis of the patient was normal but 
the serum light chains were very high making the final 
diagnosis of non secretory myeloma. So final diagnosis 
was non secretory Kappa plasma cell dyscrasia
DISCUSSION
Diabetes patients who have changes suggestive of 
demyelination on nerve conduction studies (NCS) are 
usually considered to have a superimposed 
immune-mediated polyneuropathy, such as chronic 
inflammatory demyelinating polyneuropathy (CIDP)[3]. 
The differentiation of CIDP from DSP in patients with 
diabetes is important due to the implications for 
therapy and prognosis[4]. The finding of raised CSF 
proteins helped us in making the diagnosis of CIDP. In 
such difficult cases finding of raised CSF proteins 
without CSF leucocytosis further supports the diagnosis 
of CIDP[1] and this is next important investigation to 
Polyneuropathy or this presentation suggestive of CIDP 
was the main diagnostic dilemma here. Diagnosing 
CIDP is a challenge in diabetics with pre-existing 
sensorimotor polyneuropathy.Our patient had 
neurological deterioration in 02 months and had raised 
CSF proteins of 136.6mg/dl which further supported 
the diagnosis of CIDP and there was evidence of 
demyelination on nerve conduction studies, however 
undertake in this regard.The quality of evidence for the 
efficacy for intravenous immunoglobulin and plasma 
exchange is moderate to high, with plasma exchange 
providing significant short term improvement in 
disability, clinical impairment and motor nerve 
conduction velocities, although there may be rapid 
deterioration post exchange[5]. Seventy percent of 
patients of CIDP respond to one or another of the three 
standard therapies and probably 90% respond overall 
l[1]. The lack of response to treatment and minimal 
electrophysiological progressin over time should lead 
one to suspect the diagnosis and undergo 
secondlineinvestigations[1]. Same was the case in our 
patient, he did not respond to steroids so we opted for 
second line investigations and further extensive workup 
which revealed diagnosis of non secretory myeloma. 
Serum protein electrophresis has only a 60% sensitivity 
for detecting paraproteins in the context of neuropathy, 
so immunofixaton,95% sensitivity along with bence 
jones proteins and serum free light chains should be 
performed[1]. Non secretory myeloma are one of the 
rare cause of myeloma found in only 1 to 5% of the 
cases of multiple myeloma[6].They often present as 
diagnostic challenge[6].
CONCLUSION
We conclude that diagnosing CIDP in patients with 
background diabetic sensorimotor neuropathy is a 
diagnostic challenge.We also recommend diagnostic 
workup for myeloma in CIDP should not just include 
serum and urine electrophoresis but should include 
immunofixation as well as serum free light chains ratio 
especially if the response to first line therapy is 
poor.More than meets the eye,never stop at any step, 
keep on looking for the rare causes which can make a 
single unifying diagnosis of all symptoms, as in this 
case of non secretory myeloma
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newly diagnosed CIDP, patient was started on steroids. 
Plasma exchange was high risk in our patient due to 
presence of cardiovascular compromise and was 
offered but refused by patient. Patient was given 
corticosteroids along with Azathioprine for 06 weeks. At 
06 weeks he showed no improvement in his disability. 
However, he further developed malena, steroid induced 
gastropathy was confirmed on endoscopy which 
confirmed marked antral gastritis and gastric erosions. 
His haemoglobin dropped from 10.5 to 7.5 mg/dL. He 
also developed neutropenia probably due to 
azathioprine and developed marked oral ulcers and 
thrush rendering him nil by mouth. Steroids and 
azathioprine were therefore discontinued. As patient 
did not respond to first line treatment and we had 
difficulties with first line treatments. We underwent 
second-line investigations. Further diagnostic workup 
revealed raised serum free light chain. Free kappa were 
found to be >4380mg/L (range 3.3-19.4mg/L).Serum 
protein electrophoresis of the patient was normal but 
the serum light chains were very high making the final 
diagnosis of non secretory myeloma. So final diagnosis 
was non secretory Kappa plasma cell dyscrasia
DISCUSSION
Diabetes patients who have changes suggestive of 
demyelination on nerve conduction studies (NCS) are 
usually considered to have a superimposed 
immune-mediated polyneuropathy, such as chronic 
inflammatory demyelinating polyneuropathy (CIDP)[3]. 
The differentiation of CIDP from DSP in patients with 
diabetes is important due to the implications for 
therapy and prognosis[4]. The finding of raised CSF 
proteins helped us in making the diagnosis of CIDP. In 
such difficult cases finding of raised CSF proteins 
without CSF leucocytosis further supports the diagnosis 
of CIDP[1] and this is next important investigation to 
Polyneuropathy or this presentation suggestive of CIDP 
was the main diagnostic dilemma here. Diagnosing 
CIDP is a challenge in diabetics with pre-existing 
sensorimotor polyneuropathy.Our patient had 
neurological deterioration in 02 months and had raised 
CSF proteins of 136.6mg/dl which further supported 
the diagnosis of CIDP and there was evidence of 
demyelination on nerve conduction studies, however 
undertake in this regard.The quality of evidence for the 
efficacy for intravenous immunoglobulin and plasma 
exchange is moderate to high, with plasma exchange 
providing significant short term improvement in 
disability, clinical impairment and motor nerve 
conduction velocities, although there may be rapid 
deterioration post exchange[5]. Seventy percent of 
patients of CIDP respond to one or another of the three 
standard therapies and probably 90% respond overall 
l[1]. The lack of response to treatment and minimal 
electrophysiological progressin over time should lead 
one to suspect the diagnosis and undergo 
secondlineinvestigations[1]. Same was the case in our 
patient, he did not respond to steroids so we opted for 
second line investigations and further extensive workup 
which revealed diagnosis of non secretory myeloma. 
Serum protein electrophresis has only a 60% sensitivity 
for detecting paraproteins in the context of neuropathy, 
so immunofixaton,95% sensitivity along with bence 
jones proteins and serum free light chains should be 
performed[1]. Non secretory myeloma are one of the 
rare cause of myeloma found in only 1 to 5% of the 
cases of multiple myeloma[6].They often present as 
diagnostic challenge[6].
CONCLUSION
We conclude that diagnosing CIDP in patients with 
background diabetic sensorimotor neuropathy is a 
diagnostic challenge.We also recommend diagnostic 
workup for myeloma in CIDP should not just include 
serum and urine electrophoresis but should include 
immunofixation as well as serum free light chains ratio 
especially if the response to first line therapy is 
poor.More than meets the eye,never stop at any step, 
keep on looking for the rare causes which can make a 
single unifying diagnosis of all symptoms, as in this 
case of non secretory myeloma
REFERENCES:
1. Neligan A, Reilly MM, Lunn MP . CIDP: mimics and
 chameleons. PractNeurol2014;14:399-408
2. Dunnigan SK, Ebadi H, Breiner A, Katzberg HD, 
 Lovblom LE, et al. (2013) Conduction slowing in 
 diabetic sensorimotor polyneuropathy. Diabetes 
 Care 36: 3684–3690
3. Dunnigan SK, Ebadi H, Breiner A et al. Comparison 
 of diabetes patients with “demyelinating” diabetic 
 sensorimotor polyneuropathy to those diagnosed 
 with CIDP.BrainBehav. 2013 Nov; 3(6): 656–663.
4. Dunnigan SK, Ebadi H, Breiner A et al. The 
 Characteristics of Chronic Inflammatory 
 Demyelinating Polyneuropathy in Patients with and 
 without Diabetes – An Observational Study. PLoS 
 One. 2014; 9(2): e89344.
5. Mehndiratta MM, Hughes RA. Plasma exchange for 
 chronic inflammatory demyelinating 
 polyradiculoneuropathy. Cochrane Database Syst 
 Rev 2012;9:CD003906 
6. Middela S, Kanse P. Non secretory multiple 
 myeloma. Indian J orthop 2009; 43(4): 408-411
Figure 3.MRI lumbosacral spine of the patient showing mild to moderate lumbar spondylosis.
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